BIOMAT Database Logo BIOMAT Database Logo

Hereditary angioedema: a current state-of-the-art review, V: attenuated androgens for the treatment of hereditary angioedema. 2008

Aleena Banerji, and David E Sloane, and Albert L Sheffer
Division of Rheumatology, Immunology and Allergy, Harvard Medical School/Massachusetts General Hospital, Boston, Massachusetts, USA.

OBJECTIVE To provide a summary of the literature regarding the use of attenuated androgens during the past 40 to 50 years for the treatment of hereditary angioedema (HAE). METHODS MEDLINE and PubMed were searched to identify studies involving the treatment of HAE with androgens. METHODS Studies were selected based on their relevance to the use of androgens for the treatment of HAE. RESULTS Attenuated androgens have proven successful for the short- and long-term treatment of HAE. Adverse effects are still concerning, and their use in children and pregnant women must be undertaken with great caution. Scheduled monitoring of liver function tests and lipid profiles in patients treated with these medications is critical. CONCLUSIONS Attenuated androgens have been successful in the short- and long-term treatment of HAE, and they are still the most frequently used medications in the United States for the treatment of this disease. There is a lack of readily available options for the treatment of acute HAE attacks apart from the administration of fresh frozen plasma or safe prophylactic therapies; however, several appropriate agents currently in clinical trials in the United States appear promising.

UI MeSH Term Description Entries
D008297 Male Males
D010110 Oxymetholone A synthetic hormone with anabolic and androgenic properties. It is used mainly in the treatment of anemias. According to the Fourth Annual Report on Carcinogens (NTP 85-002), this compound may reasonably be anticipated to be a carcinogen. (From Merck Index, 11th ed) Hydroxymetholone,Anadrol,Anapolon 50,Oxymethalone,Oxymetholone, (17 beta)-Isomer,Oxymetholone, (5 alpha,17 alpha)-Isomer
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003613 Danazol A synthetic steroid with antigonadotropic and anti-estrogenic activities that acts as an anterior pituitary suppressant by inhibiting the pituitary output of gonadotropins. It possesses some androgenic properties. Danazol has been used in the treatment of endometriosis and some benign breast disorders. Azol,Cyclomen,Danatrol,Danazant,Danazol-Ratiopharm,Danocrine,Danol,Danoval,Ladogal,Norciden,Panacrine,Danazol Ratiopharm
D004965 Estrogen Antagonists Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. Estradiol Antagonists,Antagonists, Estradiol,Antagonists, Estrogen
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000728 Androgens Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power. Androgen,Androgen Receptor Agonist,Androgen Effect,Androgen Effects,Androgen Receptor Agonists,Androgenic Agents,Androgenic Compounds,Agents, Androgenic,Agonist, Androgen Receptor,Agonists, Androgen Receptor,Compounds, Androgenic,Effect, Androgen,Effects, Androgen,Receptor Agonist, Androgen,Receptor Agonists, Androgen
D013197 Stanozolol A synthetic steroid that has anabolic and androgenic properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1194) Androstanazol,Methylstanazol,Stanazolol,Stromba,Winstrol

Related Publications

Aleena Banerji, and David E Sloane, and Albert L Sheffer
Hereditary angioedema: a current state-of-the-art review, III: mechanisms of hereditary angioedema.
January 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
Aleena Banerji, and David E Sloane, and Albert L Sheffer
Hereditary angioedema: a current state-of-the-art review, I: introduction.
January 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
Aleena Banerji, and David E Sloane, and Albert L Sheffer
Hereditary angiodema: a current state-of-the-art review, VI: novel therapies for hereditary angioedema.
January 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
Aleena Banerji, and David E Sloane, and Albert L Sheffer
Hereditary angioedema: a current state-of-the-art review, IX: the US Hereditary Angioedema Association: a message from the president.
January 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
Aleena Banerji, and David E Sloane, and Albert L Sheffer
Hereditary angioedema: a current state-of-the-art review, VIII: current status of emerging therapies.
January 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
Aleena Banerji, and David E Sloane, and Albert L Sheffer
Hereditary angioedema: a current state-of-the-art review, II: historical perspective of non-histamine-induced angioedema.
January 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
Aleena Banerji, and David E Sloane, and Albert L Sheffer
Management of pregnancies in a hereditary angioedema patient after treatment with attenuated androgens since childhood.
January 2015, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology,
Aleena Banerji, and David E Sloane, and Albert L Sheffer
Long-term treatment of hereditary angioedema with attenuated androgens: a survey of a 13-year experience.
April 1991, The Journal of allergy and clinical immunology,
Aleena Banerji, and David E Sloane, and Albert L Sheffer
[Current treatment options for hereditary angioedema].
January 2016, Vnitrni lekarstvi,
Aleena Banerji, and David E Sloane, and Albert L Sheffer
Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema.
January 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
Copied contents to your clipboard!